Finance

Lists
ELAN:BMV
Elanco Animal Health Inc
MX$392.00
0.00%
(0.00) 1D
Dec 16, 1:10:36 PM GMT-6  ·   MXN
All symbols
SymbolPriceChange% Change
Generating top insights for ELAN...
Mkt. cap
11.58B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$399.50
52-wk low
MX$262.00
No. of employees
10K
Mkt. cap
11.58B
Avg. vol.
0.00
Volume
0.00
52-wk high
MX$399.50
52-wk low
MX$262.00
No. of employees
10K
Profile
Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested. It is the third-largest animal health company in the world. Wikipedia
About Elanco Animal Health Inc
CEOJeffrey N. Simmons
Employees9.65K
Founded1954
HeadquartersIndianapolis, Indiana, United States
SectorPharmaceutical industry
Websiteelanco.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.14B
1.14B
1.37B
1.37B
Cost of goods sold
530.00M
555.00M
586.00M
570.00M
Cost of revenue
530.00M
555.00M
586.00M
570.00M
Research and development expenses
89.00M
93.00M
97.00M
92.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
351.00M
331.00M
381.00M
449.00M
Operating expense
580.00M
563.00M
616.00M
680.00M
Total operating expenses
1.11B
1.12B
1.20B
1.25B
Operating income
27.00M
26.00M
169.00M
118.00M
Other non operating income
2.00M
-15.00M
-8.00M
-11.00M
EBT including unusual items
-50.00M
-259.00M
87.00M
56.00M
EBT excluding unusual items
-25.00M
-37.00M
103.00M
65.00M
Income tax expense
-16.00M
17.00M
30.00M
2.00M
Effective tax rate
32.00%
-6.56%
34.48%
3.57%
Other operating expenses
-
-
-
-
Net income
-34.00M
-276.00M
57.00M
54.00M
Net profit margin
-2.99%
-24.13%
4.16%
3.95%
Earnings per share
0.19
0.13
0.40
0.34
Interest and investment income
-
45.00M
-
-
Interest expense
-52.00M
-105.00M
-57.00M
-59.00M
Net interest expenses
-52.00M
-60.00M
-57.00M
-59.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
195.00M
194.00M
335.00M
283.00M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps